Aminoglycoside
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
83 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 3 | 3 | 3 | 2 | 6 | 15 |
| Communicable diseases | D003141 | — | — | 2 | 2 | 3 | 1 | 3 | 10 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | 1 | 2 | 2 | 4 | 9 |
| Pneumonia | D011014 | EFO_0003106 | — | — | 3 | 4 | 1 | 1 | 8 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 1 | 1 | — | 2 | 3 | 7 |
| Fibrosis | D005355 | — | — | — | 2 | — | 1 | 2 | 5 |
| Toxemia | D014115 | — | — | — | 1 | 1 | 1 | 1 | 4 |
| Neoplasms | D009369 | — | C80 | — | — | 2 | 1 | 1 | 4 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 2 | — | 1 | 1 | 4 |
| Neutropenia | D009503 | — | D70 | — | — | 1 | 1 | 1 | 3 |
Show 10 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Septic shock | D012772 | — | A48.3 | — | — | 2 | — | 3 | 5 |
| Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | — | 2 | 2 | — | — | 4 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | 1 | 1 | — | 1 | 4 |
| Ototoxicity | D000081015 | — | — | — | 3 | 1 | — | 1 | 4 |
| Intraabdominal infections | D059413 | — | — | 1 | 1 | 2 | — | — | 3 |
| Febrile neutropenia | D064147 | — | — | — | — | 1 | — | 1 | 2 |
| Hyperthermia | D000084462 | — | — | — | — | 1 | — | 1 | 2 |
| Hearing loss | D034381 | EFO_0004238 | H91.9 | — | 1 | 1 | — | 1 | 2 |
| Multidrug-resistant tuberculosis | D018088 | EFO_0007381 | — | — | — | 1 | — | 1 | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | 2 | — | — | 2 |
Show 12 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inborn genetic diseases | D030342 | EFO_0000508 | — | 2 | 1 | — | — | — | 3 |
| Nonsense codon | D018389 | — | — | 2 | 1 | — | — | — | 3 |
| Healthcare-associated pneumonia | D000077299 | — | — | — | 1 | — | — | — | 1 |
| Burns | D002056 | — | T30.0 | 1 | 1 | — | — | — | 1 |
| Epidermolysis bullosa | D004820 | — | Q81 | 1 | 1 | — | — | — | 1 |
| Junctional epidermolysis bullosa | D016109 | — | Q81.1 | 1 | 1 | — | — | — | 1 |
| Necrotizing enterocolitis | D020345 | EFO_0003928 | K55.3 | 1 | 1 | — | — | — | 1 |
| Enterocolitis | D004760 | EFO_1001481 | — | 1 | 1 | — | — | — | 1 |
| Fanconi syndrome | D005198 | — | — | — | 1 | — | — | — | 1 |
| Cystinosis | D003554 | — | E72.04 | — | 1 | — | — | — | 1 |
Show 7 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | HP_0001626 | — | 1 | — | — | — | — | 1 |
| Diet therapy | D004035 | — | — | 1 | — | — | — | — | 1 |
| Renal dialysis | D006435 | EFO_0010690 | Z99.2 | 1 | — | — | — | — | 1 |
| Bacterial vaginosis | D016585 | EFO_0003932 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 5 | 5 |
| Critical illness | D016638 | — | — | — | — | — | — | 3 | 3 |
| Bacterial infections | D001424 | — | A49 | — | — | — | — | 2 | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 2 | 2 |
| Inappropriate prescribing | D057970 | — | — | — | — | — | — | 1 | 1 |
| Shock | D012769 | — | R57.1 | — | — | — | — | 1 | 1 |
| Inhalation administration | D000280 | — | — | — | — | — | — | 1 | 1 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
| Renal tubular acidosis | D000141 | — | N25.89 | — | — | — | — | 1 | 1 |
| Urolithiasis | D052878 | — | N20-N23 | — | — | — | — | 1 | 1 |
Show 18 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use